Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia

Published:2024-01 Issue:1 Volume:27 Page:134-144
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Al-Abdulkarim Hana¹²³,Sharma Yuvraj⁴,Attar Suzan M.⁵,Husain Waleed⁶,Al-Homood Ibrahim⁷,Al Omari Bedor⁸,Mohamed Omneya⁹,Alsaqa’aby Mai¹⁰^ORCID,Jaheen Ahmed M.¹¹,Anwar Ali¹¹,Hamad Tharwat M.¹¹,Alzahrani Zeyad¹²

Affiliation:

1. National Guard Health Affairs, Riyadh, Saudi Arabia

2. King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia

3. Doctoral School of Applied Informatics and Applied Mathematics, Óbuda University, Budapest, Hungary

4. IQVIA, London, UK

5. Rheumatology & Internal Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

6. Heraa Hospital, Makkah, Saudi Arabia

7. Internal Medicine Department, King Fahad Medical City, Riyadh, Saudi Arabia

8. Pharmaceutical Care Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

9. Real-World Evidence (RWE), IQVIA AG, Dubai, United Arab Emirates

10. Real-World Evidence (RWE), IQVIA Solutions, Riyadh, Saudi Arabia

11. Branch of AbbVie Biopharmaceuticals GmbH, Scientific Office, Riyadh, Saudi Arabia

12. Department of Surgery, King Abdulaziz Medical City, Jeddah, Saudi Arabia

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2299176

Reference59 articles.

Rheumatoid Arthritis Saudi Database (RASD): Disease Characteristics and Remission Rates in a Tertiary Care Center

2. Assessment of health-related quality of life, anxiety and depression in patients with early rheumatoid arthritis

3. Rheumatoid arthritis in Saudi Arabia;Almoallim HM;Saudi Med J,2014

4. One year in review 2018: pathogenesis of rheumatoid arthritis;Calabresi E;Clin Exp Rheumatol,2018

5. Epidemiology of Rheumatoid Arthritis: Rheumatoid Arthritis and Mortality